<DOC>
	<DOCNO>NCT00758680</DOCNO>
	<brief_summary>This study asses safety , tolerability , multiple-dose pharmacokinetics pharmacodynamics MK1006 participant type 2 diabetes .</brief_summary>
	<brief_title>A Multiple-Dose Study MK-1006 ( MK-1006-004 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<criteria>Participant BMI less equal 42 kg/m^2 screen visit Participant diagnose Type 2 Diabetes treat either diet exercise alone single combination oral antihyperglycemic medication Participant willing follow diet contain approximately 50 % carbohydrate , 20 % protein , 30 % fat study Participant nonsmoker use nicotine containing product ~ 6 month start study Participant must treat three oral antihyperglycemic medication , insulin , PPARgamma agonists Participant history stroke , chronic seizure , major neurological disorder Participant eye infection inflammatory eye condition within 2 week first dose study drug Participant glaucoma blind Participant condition know related cataract development Participant incisional eye surgery within 6 month screen laser surgery ( Lasik ) within 3 month screen Participant history type 1 diabetes ketoacidosis Participant stop take certain current medication study Participant consumes great 3 alcoholic beverage per day Participant consume 6 serving caffeinated beverage per day ( 1 serve ~ 120 mg caffeine ) Participant history significant multiple severe allergy reaction intolerant prescription/nonprescription drug food Participant use recreational drug history drug abuse within 6 month start study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>